Deferiprone

Prescrire International

Volumn 9, Issue 49, 2000, Pages 131-135

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN; HEMOGLOBIN A; IRON; IRON CHELATING AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; PYRIDONE DERIVATIVE;

AGRANULOCYTOSIS; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CARDIOMEGALY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CARCINOGENICITY; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; EUROPE; FERRITIN BLOOD LEVEL; GASTROINTESTINAL DISEASE; GENETIC DISORDER; GROWTH RETARDATION; HEARING DISORDER; HEPATOMEGALY; HUMAN; INFECTION SENSITIVITY; IRON OVERLOAD; LICENCE; LIVER FIBROSIS; LIVER TOXICITY; LONG TERM CARE; MYALGIA; NAUSEA AND VOMITING; NEUTROPENIA; NONHUMAN; PATIENT MONITORING; POLYARTHRITIS; RABBIT; RAT; RISK ASSESSMENT; SIDE EFFECT; SPLENECTOMY; SPLENOMEGALY; STOMACH DISEASE; TABLET FORMULATION; TERATOGENICITY; THROMBOCYTOPENIA; TREATMENT OUTCOME; URINE COLOR; VISUAL DISORDER; ZINC DEFICIENCY; CANADA; CHEMICALLY INDUCED DISORDER;

AGRANULOCYTOSIS; BETA-THALASSEMIA; CANADA; CLINICAL TRIALS; EUROPE; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; PYRIDONES; TREATMENT OUTCOME;

EID: 0034305121     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. "Final results of the randomized trial of deferiprone (L1) and deferoxamine (DFO)"
2. "Final results of the randomized trial of deferiprone (LI) and deferoxamine (DFO)"
3. "Iron chelation therapy with oral deferiprone - Toxicity or lack of efficacy"
4. "A multi-center safety trial of the oral iron chelator deferiprone"
5. "Olivieri sues EU over deferirprone"
6. "Meta-analytic review of the clinical effectiveness of oral deferiprone (LI)"
7. "Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients"
8. "Liver iron and fibrosis during long-term treatment with deferiprone in Swiss thallassemia patients"
9. "Oral iron chelating therapy. A single center interim report of deferiprone (LI) in thalassemia"
10. "An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major"
11. "Efficacy and side effects of deferiprone (L1) in thalassemia patients not compliant with desferrioxamine"
12. "Longterm follow-up of 56 patients commencing deferiprone therapy"
13. "Long-term treatment of transfusional iron overload with the oral iron chelator deferiprone (1): A Dutch multi-center trial"
14. "Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs"
15. "Desféral°/"
16. "Toxicity of oral iron chelator LI"
17. "Development of oral iron chelator LI"
18. "Law notes case pending before the European Court of Justice"
19. "Ironn-chelation therapy with oral deferiprone in patients with thalassemia major"